Envoy Medical, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $51.0K | $39.0K | $75.0K | $42.0K | $78.0K | $46.0K | $42.0K | $56.0K |
| Cost of Revenue | $278.0K | $313.0K | $211.0K | $203.0K | $234.0K | $226.0K | $157.0K | $187.0K |
| Gross Profit | $-227.0K | $-274.0K | $-136.0K | $-161.0K | $-156.0K | $-180.0K | $-115.0K | $-131.0K |
| Gross Margin | -445.1% | -702.6% | -181.3% | -383.3% | -200.0% | -391.3% | -273.8% | -233.9% |
| Operating Expenses | ||||||||
| Research & Development | $3.1M | $3.6M | $4.6M | $2.7M | $2.5M | $2.7M | $2.5M | $2.8M |
| SG&A Expense | $2.0M | $1.9M | $1.6M | $2.4M | $2.1M | $1.8M | $1.4M | $1.7M |
| Operating Income | $-5.6M | $-6.0M | $-6.4M | $-5.7M | $-5.1M | $-5.1M | $-4.5M | $-5.0M |
| Operating Margin | -10,919.6% | -15,279.5% | -8,513.3% | -13,590.5% | -6,500.0% | -11,102.2% | -10,828.6% | -8,878.6% |
| Interest Expense | — | — | — | — | $624.0K | $495.0K | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-6.0M | $-4.4M | $-6.6M | $-6.5M | $-5.7M | $-5.0M | $-4.6M | $-6.0M |
| Net Margin | -11,729.4% | -11,156.4% | -8,781.3% | -15,433.3% | -7,294.9% | -10,865.2% | -10,995.2% | -10,642.9% |
| EPS (Basic) | $-0.07 | $-0.08 | $-0.27 | $-0.35 | $-0.32 | $-0.29 | $-0.40 | $-0.39 |
| EPS (Diluted) | $-0.07 | $-0.08 | $-0.27 | $-0.35 | $-0.32 | $-0.29 | $-0.40 | $-0.39 |
| Shares Outstanding (Basic) | 104.0M | 68.9M | 23.3M | 21.9M | 21.4M | 21.3M | 18.8M | 18.6M |
| Shares Outstanding (Diluted) | 104.0M | 68.9M | 23.3M | 21.9M | 21.4M | 21.3M | 18.8M | 18.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |